Terms: = Germ cell tumor AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS
311 results:
1. Extracellular vesicles from highly invasive melanoma subpopulations increase the invasive capacity of less invasive melanoma cells through mir-1246-mediated inhibition of CCNG2.
Kingreen T; Kewitz-Hempel S; Rohde C; Hause G; Sunderkötter C; Gerloff D
Cell Commun Signal; 2024 Sep; 22(1):442. PubMed ID: 39285403
[TBL] [Abstract] [Full Text] [Related]
2. Role of surgery in the treatment of pediatric low-grade glioma with various degrees of brain stem involvement.
Lorincz KN; Gorodezki D; Schittenhelm J; Zipfel J; Tellermann J; Tatagiba M; Ebinger M; Schuhmann MU
Childs Nerv Syst; 2024 Oct; 40(10):3037-3050. PubMed ID: 39145885
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic performance of 3.0 Tesla diffusion tensor imaging in the assessment of brain stem glioma grading.
Viet Anh D; Thanh Van Anh N; Ha Khuong N; He DV; Duy Hung N
Clin Ter; 2024; 175(4):239-245. PubMed ID: 39010808
[TBL] [Abstract] [Full Text] [Related]
4. The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas.
Kinslow CJ; Roy S; Iwamoto FM; Brown PD; DeStephano DM; Canoll PD; Qureshi SS; Gallito M; Sisti MB; Bruce JN; Horowitz DP; Kachnic LA; Neugut AI; Yu JB; Mehta MP; Cheng SK; Wang TJC
Neuro Oncol; 2024 Oct; 26(10):1839-1849. PubMed ID: 38943513
[TBL] [Abstract] [Full Text] [Related]
5. Dosimetric evaluation and treatment planning considerations for GammaTile permanent brain implants - a pilot, institutional experience.
Zhang S; Patel K; Dusenbery K; Alshreef A; Sterling D; Sloan L; Reynolds M; Chen CC; Ferreira C
J Neurooncol; 2024 Aug; 169(1):11-23. PubMed ID: 38902561
[TBL] [Abstract] [Full Text] [Related]
6. Impact of Pheochromocytoma or Paraganglioma on Bone Metabolism: A Systemic Review and Meta-analysis.
Dutta D; Nagendra L; Chandran M; Sharma M; Bhattacharya S; Mukhopadhyay S
J Clin Densitom; 2024; 27(3):101501. PubMed ID: 38796986
[TBL] [Abstract] [Full Text] [Related]
7. The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian Cohort.
Zijlker LP; Chen H; Spillane AJ; Gonzalez M; Pennington TE; Menzies AM; Lo SN; Ferguson P; Rawson R; Colebatch AJ; Stretch JR; Thompson JF; Ch'ng S; Nieweg O; Shannon KF; Long GV; Scolyer RA; Saw RPM; van Akkooi ACJ
Ann Surg Oncol; 2024 Aug; 31(8):5324-5330. PubMed ID: 38762644
[TBL] [Abstract] [Full Text] [Related]
8. Effectiveness of Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcoma in Older Patients.
Kinoshita H; Yonemoto T; Yamada S; Imai R
Anticancer Res; 2024 Apr; 44(4):1773-1780. PubMed ID: 38537982
[TBL] [Abstract] [Full Text] [Related]
9. germline cancer susceptibility in individuals with melanoma.
Funchain P; Ni Y; Heald B; Bungo B; Arbesman M; Behera TR; McCormick S; Song JM; Kennedy LB; Nielsen SM; Esplin ED; Nizialek E; Ko J; Diaz-Montero CM; Gastman B; Stratigos AJ; Artomov M; Tsao H; Arbesman J
J Am Acad Dermatol; 2024 Aug; 91(2):265-272. PubMed ID: 38513832
[TBL] [Abstract] [Full Text] [Related]
10. Genomic drivers in craniopharyngiomas: Analysis of the AACR project GENIE database.
Lehrich MB; Tong CLC; Hsu PKF; Kuan CE
Childs Nerv Syst; 2024 Jun; 40(6):1661-1669. PubMed ID: 38421446
[TBL] [Abstract] [Full Text] [Related]
11. A meta-analysis comparing efficacy and safety between proton beam therapy versus carbon ion radiotherapy.
Jang JY; Kim K; Chen MF; Akimoto T; Wang MLC; Kim MJ; Kim K; Lee TH; Yoo GS; Park HC
Cancer Med; 2024 Feb; 13(3):e7023. PubMed ID: 38396380
[TBL] [Abstract] [Full Text] [Related]
12. Differentiation States of Phenotypic Transition of Melanoma cells Are Revealed by 3D cell Cultures.
Fontana F; Sommariva M; Anselmi M; Bianchi F; Limonta P; Gagliano N
Cells; 2024 Jan; 13(2):. PubMed ID: 38247872
[TBL] [Abstract] [Full Text] [Related]
13. Early postoperative prediction of the risk of distant metastases in medullary thyroid cancer.
Zhang Y; Zhou Q; Chen G; Xue S
Front Endocrinol (Lausanne); 2023; 14():1209978. PubMed ID: 38075078
[TBL] [Abstract] [Full Text] [Related]
14. Clinical and Magnetic Resonance Imaging Radiomics-Based Survival Prediction in Glioblastoma Using Multiparametric Magnetic Resonance Imaging.
Bathla G; Soni N; Ward C; Pillenahalli Maheshwarappa R; Agarwal A; Priya S
J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):919-923. PubMed ID: 37948367
[TBL] [Abstract] [Full Text] [Related]
15. Added prognostic value of 3D deep learning-derived features from preoperative MRI for adult-type diffuse gliomas.
Lee JO; Ahn SS; Choi KS; Lee J; Jang J; Park JH; Hwang I; Park CK; Park SH; Chung JW; Choi SH
Neuro Oncol; 2024 Mar; 26(3):571-580. PubMed ID: 37855826
[TBL] [Abstract] [Full Text] [Related]
16. Machine learning for differentiation of lipid-poor adrenal adenoma and subclinical pheochromocytoma based on multiphase CT imaging radiomics.
Xiao DX; Zhong JP; Peng JD; Fan CG; Wang XC; Wen XL; Liao WW; Wang J; Yin XF
BMC Med Imaging; 2023 Oct; 23(1):159. PubMed ID: 37845636
[TBL] [Abstract] [Full Text] [Related]
17. Ovarian squamous cell carcinoma associated with teratoma: a report of six cases with genomic analysis.
Liang Y; Ruan H; Yu M; Lü B
Pathology; 2023 Dec; 55(7):966-973. PubMed ID: 37739924
[TBL] [Abstract] [Full Text] [Related]
18. Association of tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis.
Ballo MT; Conlon P; Lavy-Shahaf G; Kinzel A; Vymazal J; Rulseh AM
J Neurooncol; 2023 Aug; 164(1):1-9. PubMed ID: 37493865
[TBL] [Abstract] [Full Text] [Related]
19. A tumor and Immune-Related Micro-RNA Signature Predicts Relapse-Free Survival of Melanoma Patients Treated with Ipilimumab.
Kobeissi I; Eljilany I; Achkar T; LaFramboise WA; Santana-Santos L; Tarhini AA
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175874
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model.
Duan X; Yang B; Zhao C; Tie B; Cao L; Gao Y
BMC Cancer; 2023 May; 23(1):432. PubMed ID: 37173662
[TBL] [Abstract] [Full Text] [Related]
[Next]